GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Sinobioway Biomedicine Co Ltd (SZSE:002581) » Definitions » PEG Ratio

Shandong Sinobioway Biomedicine Co (SZSE:002581) PEG Ratio : N/A (As of Dec. 14, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Sinobioway Biomedicine Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Shandong Sinobioway Biomedicine Co's PE Ratio without NRI is 0.00. Shandong Sinobioway Biomedicine Co's 5-Year EBITDA growth rate is 0.00%. Therefore, Shandong Sinobioway Biomedicine Co's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Shandong Sinobioway Biomedicine Co's PEG Ratio or its related term are showing as below:


During the past 13 years, Shandong Sinobioway Biomedicine Co's highest PEG Ratio was 9.37. The lowest was 0.88. And the median was 2.70.


SZSE:002581's PEG Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.93
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Shandong Sinobioway Biomedicine Co PEG Ratio Historical Data

The historical data trend for Shandong Sinobioway Biomedicine Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sinobioway Biomedicine Co PEG Ratio Chart

Shandong Sinobioway Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shandong Sinobioway Biomedicine Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shandong Sinobioway Biomedicine Co's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Sinobioway Biomedicine Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sinobioway Biomedicine Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Sinobioway Biomedicine Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Shandong Sinobioway Biomedicine Co's PEG Ratio falls into.



Shandong Sinobioway Biomedicine Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Shandong Sinobioway Biomedicine Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Shandong Sinobioway Biomedicine Co  (SZSE:002581) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Shandong Sinobioway Biomedicine Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Shandong Sinobioway Biomedicine Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sinobioway Biomedicine Co Business Description

Traded in Other Exchanges
N/A
Address
No.18, Chaoyang Road, Zhangdian District, Zibo City, Shandong, CHN, 255068
Shandong Sinobioway Biomedicine Co Ltd is engaged in the research, development, manufacturing and marketing of trimethyl orthoformate and triethyl orthoformate.
Executives
He Xun Executives
Yang Xiao Min Director
Yu Tong Jie Executives
Yan Li Director

Shandong Sinobioway Biomedicine Co Headlines

No Headlines